Board of Directors

The Board of Directors, comprised of leading COPD experts, is GOLD’s main governing body. It encourages dissemination and adoption of the reports on COPD management through utilization of existing health care structures in individual countries and promotes international collaboration on COPD research.


Alvar G. Agusti, MD, Chair
Director, Institut Clínic del Tòrax
Hospital Clínic, Universitat de Barcelona
Villarroel 170
08036 Barcelona, Spain

Richard Beasley, MD
Director of the Medical Research Institute of New Zealand
Professor of Medicine at Victoria University Wellington

Bartolome R. Celli, MD
Brigham and Women's Hospital
Pulmonary Division
75 Francis Street, PBB Clinics 3
Boston, MA, 02115, USA

Rongchang Chen, MD
Guangzhou Institute of Respiratory Disease
(State Key Lab of Respiratory Disease & National Clinical Research Center for Respiratory Disease)
First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China

Gerard Criner, MD
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Temple University School of Medicine
Philadelphia, PA 19140 USA

Peter Frith, MD
Southern Respiratory Services
Repatriation General Hospital, Adelaide
South Australia, Australia

David Halpin, MD
Royal Devon and Exeter Hospital
Devon, United Kingdom

M. Victorina López Varela, MD
Cátedra de Neumología
Facultad de Medicina
Universidad de la República, Hospital Maciel
Montevideo, Uruguay

Kevin Mortimer MD
Liverpool School of Tropical Medicine
Liverpool, United Kingdom

Sundeep Salvi MD, PhD, FCCP, FRCP
Director, Chest Research Foundation
Marigold Complex
Pune 411014, India

Claus Vogelmeier, MD
Director, Internal Medicine Clinic
University of Gießen and Marburg
School of Medicine
Standort Marburg Baldingerstraße
D-35043 Marburg, Germany

GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

View Board and Committee Annual Disclosures